Fonterra Research Centre   Report issue

For profit Phase 3
Founded: Auckland New Zealand (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2009
NCT01171014
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Fonterra (Europe) Cooperatie U.A. | Fonterra Research Centre

Active Ingredients

Drugs in Phase 3 Trials (1)

bifidobacterium lactis (3 trials)

Drugs in Other Trials (4)

anmum materna (1 trial)

bifidobacterium animalis (1 trial)

cow milk (1 trial)

lactobacillus rhamnosus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 3)

Influenza, Human (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 5